Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mizuho Maintains Neutral on Sage Therapeutics, Raises Price Target to $45

Mizuho analyst Vamil Divan maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and raises the price target from $37 to $45.
byBenzinga Newsdesk
February 17, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Mizuho analyst Vamil Divan maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and raises the price target from $37 to $45.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts